Advocacy

Advocacy in Action

February 23, 2024

Society Continues to Advocate for Expanded Access to Telehealth 

The Endocrine Society continues to be a leading voice in advocating for expanded access to telehealth services. This week, the Society urged leaders in Congress to pass legislation to make the existing telehealth flexibilities permanent before they expire at the end of 2024. These flexibilities, which were originally put in place during the COVID-19 pandemic, have ensured that endocrinologists can continue to deliver care via telehealth to patients across the country, including the more than 30 million people on Medicare. The Society has also endorsed the Telehealth Modernization Act, bipartisan legislation that would ensure patients can access telehealth services anywhere by permanently removing Medicare’s “geographic and originating site” rule. We will continue to urge Congress to pass legislation that expands access to telehealth and protects the flexibilities currently in place.

Endocrine Society Identifies Improvements for EDC Screening Program

This week, we made recommendations to the United States Environmental Protection Agency (EPA) in response to an announcement of a near-term strategy to improve the Endocrine Disruptors Screening Program (EDSP). While we are encouraged that the EPA intends to reinvigorate the program to better assess hazards from exposures to EDCs, in our comments we expressed concern that the strategy does not resolve many issues that the public expects EPA to address.  Specifically, we call on EPA to act with greater urgency to assesses chemicals for effects on endocrine systems beyond estrogen, androgen, thyroid and steroidogenesis (EATS), including pathways underlying prevalent human chronic diseases, and utilize an expanded suite of more sensitive endpoints to assess a broader range of chemicals for endocrine disruption during important biological stages more effectively. The Endocrine Society, led by our US EDC Task Force, will continue to engage with EPA as the EDSP strategy is refined and implemented to ensure that we can protect the public from harms associated with exposure to EDCs.

EU Proposes Science-Based Restrictions on Bisphenols

Following the European Food Safety Authority (EFSA) updated opinion on bisphenol-A (BPA), which indicated a concern for human health at extremely low levels of exposure, the European Commission announced a proposal to ban BPA in food contact materials (FCM) including plastic packaging and coatings. The Commission’s proposal also goes a step further by introducing restrictions on derivatives of BPA to prevent substitutions with other bisphenols with potentially similar hazardous properties. The Endocrine Society welcomes the new proposal, which is based on a systematic review of the latest science on BPA, including results from the Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA). The Society’s EU Endocrine Disrupting Chemicals (EDCs) Task Force has provided expert guidance to European agencies and the Commission on every step of this process, from suggesting studies to inform EFSA’s systematic review, to providing commentary on the draft opinion, and finally encouraging the Commission to prioritize this important regulation. We enthusiastically support the provisions to address BPA derivatives, which is consistent with our recommended approach for group-based restrictions on similar chemicals.

Clinical Endocrinology Mentorship Opportunity at ENDO2024

The Endocrine Society will host the second annual Endocrinology Mentor Day (eMD) at ENDO 2024 in Boston. The event will take place on Sunday, June 2. During the event, medical students and residents will be paired with an Endocrine Society member as their “mentor” for the day. Mentors will guide attendees around ENDO and introduce them to ENDO’s signature programs, including poster presentations, interesting case studies, and a plenary session. The event at ENDO 2023 in Chicago last year was a big success, due in large part to our terrific mentors. If you are interested in joining us for this program as a mentor, or would like to learn more about the event, please email Ellie Cliff at ecliff@endocrine.org.

Last Updated:
Take Action

Make Your Voice Heard

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.